Arterra Bioscience SpA Ordinary Shares ABS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €1.80
- Day Range
- €1.78–1.87
- 52-Week Range
- €1.48–2.50
- Bid/Ask
- €1.76 / €1.92
- Market Cap
- €12.18 Mil
- Volume/Avg
- 21,750 / 16,167
Key Statistics
- Price/Earnings (Normalized)
- 10.89
- Price/Sales
- 2.37
- Dividend Yield (Trailing)
- 5.56%
- Dividend Yield (Forward)
- 5.56%
- Total Yield
- 5.26%
Company Profile
Arterra Bioscience SpA is a biotechnology company focused on the research and development of ingredients and natural solutions. It engages in the development of technological platforms, employed in the screening of active compounds for different industrial applications; setting up of new extraction processes, aimed at improving the sustainability and yield of interesting compounds; and production of high-tech raw materials with application in different industrial fields.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 30
- Website
- https://www.arterrabio.it
Valuation
|
Metric
|
ABS
|
|---|---|
Price/Earnings (Normalized) | 10.89 |
Price/Book Value | 1.09 |
Price/Sales | 2.37 |
Price/Cash Flow | — |
Price/Earnings
ABS
Financial Strength
|
Metric
|
ABS
|
|---|---|
Quick Ratio | 6.24 |
Current Ratio | 8.05 |
Interest Coverage | 226.18 |
Quick Ratio
ABS
Profitability
|
Metric
|
ABS
|
|---|---|
Return on Assets (Normalized) | 8.31% |
Return on Equity (Normalized) | 10.13% |
Return on Invested Capital (Normalized) | 9.67% |
Return on Assets
ABS
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Gxxbkmbpq | Stn | $562.4 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Xgfwvzjjq | Jkmhcy | $103.6 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Gzxmmnvq | Fhgpsz | $99.5 Bil | |
MRNA
| Moderna Inc | Sfbpltf | Cph | $38.8 Bil | |
ARGX
| argenx SE ADR | Cwhjywcs | Vfcbb | $22.3 Bil | |
BNTX
| BioNTech SE ADR | Rydckpmc | Vbjq | $21.2 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Zbcbljsx | Cdxzfr | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Crqmfykp | Tnstfxv | $17.3 Bil | |
RPRX
| Royalty Pharma PLC Class A | Gnvbbbrvxf | Qyrqxt | $12.5 Bil | |
INCY
| Incyte Corp | Hswytjvp | Yprmdg | $11.6 Bil |